Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ · Healthcare
Tarsus Pharmaceuticals Inc. Revenue 2020–2025
Tarsus Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Tarsus Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 162.1 M, a 106.87% increase year-over-year.
- Tarsus Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 461.7 M, a 289.94% increase year-over-year.
- Tarsus Pharmaceuticals Inc. annual revenue for 2025 was 451.4 M, a 146.71% increase from 2024.
- Tarsus Pharmaceuticals Inc. annual revenue for 2024 was 183.0 M, a 948.62% increase from 2023.
- Tarsus Pharmaceuticals Inc. annual revenue for 2023 was 17.4 M, a 32.42% decrease from 2022.
- Tarsus Pharmaceuticals Inc. annual revenue for 2022 was 25.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tarsus Pharmaceuticals Inc. Revenue — FAQ
Tarsus Pharmaceuticals Inc. (TARS) revenue over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Tarsus Pharmaceuticals Inc.'s revenue?
Tarsus Pharmaceuticals Inc. (TARS) reported revenue of $451M for fiscal 2025.
Where can I see TARS's revenue history?
The chart and table above show Tarsus Pharmaceuticals Inc.'s revenue by year and by quarter, including the growth rate.